All Title Author
Keywords Abstract


Oncofertility in Gynecologic Malignant Tumors

DOI: 10.4236/jct.2015.614128, PP. 1176-1191

Keywords: Gynecological Cancer, Fertility Preservation, Cryopreservation, Uterine Transplantation, Pregnancy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Long-term survival is the priority in treatment of patients with malignant tumors. In the field of gynecology, fertility preservation has also recently become an important objective due to improved treatment outcomes and different needs of patients. Methods for fertility preservation include cervical conization, ovarian protection against radiation or chemotherapy for ovarian cancer since the ovary is hypersensitive to cancer therapies, treatment of gynecological cancer during pregnancy, and cryopreservation of oocytes, embryos or ovarian tissue before treatment of malignant tumors. Radical trachelectomy for early cervical cancer and treatment with medroxy progesterone acetate for early endometrial carcinoma are also options for fertility preservation, but the efficacy and risk of recurrence have yet to be fully evaluated. The first childbirth following uterine transplantation was also achieved last year and this success has expanded the potential for pregnancy and delivery among cancer survivors.

References

[1]  Loren, A.W., Mangu, P.B., Beck, L.N., Brennan, L., Magdalinski, A.J., Partridge, A.H., Quinn, G., Wallace, W.H. and Oktay, K. (2013) Fertility Preservation for Patients with Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology, 31, 2500-2510.
http://dx.doi.org/10.1200/JCO.2013.49.2678
[2]  Amant, F., Van Calsteren, K., Halaska, M.J., Beijnen, J., Lagae, L., Hanssens, M., Heyns, L., Lannoo, L., Ottevanger, N.P., Bogaert, W.V., Ungar, L., Vergote, I. and du Bois, A. (2009) Gynecologic Cancers in Pregnancy: Guidelines of an International Consensus Meeting. International Journal of Gynecological Cancer, 19, S1-S12.
http://dx.doi.org/10.1111/IGC.0b013e3181a1d0ec
[3]  Rieck, G. and Fiander, A. (2006) The Effect of Lifestyle Factors on Gynaecological Cancer. Best Practice & Research Clinical Obstetrics & Gynaecology, 20, 227-251.
http://dx.doi.org/10.1016/j.bpobgyn.2005.10.010
[4]  Miesfeldet, S., Lamb, A. and Duarte, C. (2013) Management of Genetic Syndromes Predisposing to Gynecologic Cancers. Current Treatment Options in Oncology, 14, 34-50.
http://dx.doi.org/10.1007/s11864-012-0215-3
[5]  Adachi, M., Banno, K., Yanokura, M., Iida, M., Nakamura, K., Nogami, Y., Umene, K., Masuda, K., Kisu, I., Ueki, A., Hirasawa, A., Tominaga, E. and Aoki, D. (2015) Risk-Reducing Surgery in Hereditary Gynecological Cancer: Clinical Applications in Lynch Syndrome and Hereditary Breast and Ovarian Cancer. Molecular and Clinical Oncology, 3, 267-273.
[6]  Banno, K., Yanokura, M., Iida, M., Masuda, K. and Aoki, D. (2014) Carcinogenic Mechanisms of Endometrial Cancer: Involvement of Genetics and Epigenetics. Journal of Obstetrics and Gynaecology Research, 40, 1957-1967.
http://dx.doi.org/10.1111/jog.12442
[7]  National Comprehensive Cancer Network (NCCN) (2015) Clinical Practice Guidelines in Oncology. Genetic/Familial High-Risk Assessment: Breast and Ovarian.
http://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf
[8]  National Comprehensive Cancer Network (NCCN) (2015) Clinical Practice Guidelines in Oncology. Colorectal Cancer Screening.
http://www.nccn.org/professionals/physician_gls/pdf/colorectal_screening.pdf
[9]  Sadler, L., Saftlas, A., Wang, W., Exeter, M., Whittaker, J. and McCowan, L. (2004) Treatment for Cervical Intraepithelial Neoplasia and Risk of Preterm Delivery. JAMA, 291, 2100-2106.
http://dx.doi.org/10.1001/jama.291.17.2100
[10]  Kyrgiou, M., Koliopoulos, G., Martin-Hirsch, P., Arbyn, M., Prendiville, W. and Paraskevaidis, E. (2006) Obstetric Outcomes after Conservative Treatment for Intraepithelial or Early Invasive Cervical Lesions: Systematic Review and Meta-Analysis. Lancet, 367, 489-498.
http://dx.doi.org/10.1016/S0140-6736(06)68181-6
[11]  Bruinsma, F., Lumley, J., Tan, J. and Quinn, M. (2007) Precancerous Changes in the Cervix and Risk of Subsequent Preterm Birth. BJOG: An International Journal of Obstetrics & Gynaecology, 114, 70-80.
http://dx.doi.org/10.1111/j.1471-0528.2006.01107.x
[12]  Arbyn, M., Kyrgiou, M., Simoens, C., Raifu, A.O., Koliopoulos, G., Martin-Hirsch, P., Prendiville, W. and Paraskevaidis, E. (2008) Perinatal Mortality and Other Severe Adverse Pregnancy Outcomes Associated with Treatment of Cervical Intraepithelial Neoplasia: Meta-Analysis. BMJ, 337, a1284.
http://dx.doi.org/10.1136/bmj.a1284
[13]  Noehr, B., Jensen, A., Frederiksen, K., Tabor, A. and Kjaer, S.K. (2009) Loop Electrosurgical Excision of the Cervix and Subsequent Risk for Spontaneous Preterm Delivery: A Population-Based Study of Singleton Deliveries during a 9-Year Period. American Journal of Obstetrics & Gynecology, 201, 33.e1-33.e6.
http://dx.doi.org/10.1016/j.ajog.2009.02.004
[14]  Rob, L., Skapa, P. and Robova, H. (2011) Fertility-Sparing Surgery in Patients with Cervical Cancer. The Lancet Oncology, 12, 192-200.
http://dx.doi.org/10.1016/S1470-2045(10)70084-X
[15]  Plante, M. (2008) Vaginal Radical Trachelectomy: An Update. Gynecologic Oncology, 111, S105-S110.
http://dx.doi.org/10.1016/j.ygyno.2008.07.020
[16]  Ushijima, K., Yahata, H., Yoshikawa, H., Konishi, I., Yasugi, T., Saito, T., Nakanishi, T., Sasaki, H., Saji, F., Iwasaka, T., Hatae, M., Kodama, S., Saito, T., Terakawa, N., Yaegashi, N., Hiura, M., Sakamoto, A., Tsuda, H., Fukunaga, M. and Kamura, T. (2007) Multicenter Phase II Study of Fertility-Sparing Treatment with Medroxyprogesterone Acetate for Endometrial Carcinoma and Atypical Hyperplasia in Young Women. Journal of Clinical Oncology, 25, 2798-2803.
http://dx.doi.org/10.1200/JCO.2006.08.8344
[17]  Dhar, K.K., NeedhiRajan, T., Koslowski, M. and Woolas, R.P. (2005) Is Levonorgestrel Intrauterine System Effective for Treatment of Early Endometrial Cancer? Report of Four Cases and Review of the Literature. Gynecologic Oncology, 97, 924-927.
http://dx.doi.org/10.1016/j.ygyno.2004.10.031
[18]  Minig, L., Franchi, D., Boveri, S., Casadio, C., Bocciolone, L. and Sideri, M. (2011) Progestin Intrauterine Device and GnRH Analogue for Uterus-Sparing Treatment of Endometrial Precancers and Well-Differentiated Early Endometrial Carcinoma in Young Women. Annals of Oncology, 22, 643-649.
http://dx.doi.org/10.1093/annonc/mdq463
[19]  Kim, M.K. and Seong, S.J. (2014) Conservative Treatment for Atypical Endometrial Hyperplasia: What Is the Most Effective Therapeutic Method? Journal of Gynecologic Oncology, 25, 164-165.
http://dx.doi.org/10.3802/jgo.2014.25.3.164
[20]  Kaku, T., Yoshikawa, H., Tsuda, H., Sakamoto, A., Fukunaga, M., Kuwabara, Y., Hataeg, M., Kodama, S., Kuzuya, K., Sato, S., Nishimura, T., Hiura, M., Nakano, H., Iwasaka, T., Miyazaki, K. and Kamura, T. (2001) Conservative Therapy for Adenocarcinoma and Atypical Endometrial Hyperplasia of the Endometrium in Young Women: Central Pathologic Review and Treatment Outcome. Cancer Letters, 167, 39-48.
http://dx.doi.org/10.1016/S0304-3835(01)00462-1
[21]  Imai, M., Jobo, T., Sato, R., Kawaguchi, M. and Kuramoto, H. (2001) Medroxyprogesterone Acetate Therapy for Patients with Adenocarcinoma of the Endometrium Who Wish to Preserve the Uterus: Usefulness and Limitations. European Journal of Gynaecological Oncology, 22, 217-220.
[22]  Utsunomiya, H., Suzuki, T., Ito, K., Moriya, T., Konno, R., Sato, S., Yaegashi, N., Okamura, K. and Sasano, H. (2003) The Correlation between the Response to Progestogen Treatment and the Expression of Progesterone Receptor B and 17β-Hydroxysteroid Dehydrogenase Type 2 in Human Endometrial Carcinoma. Clinical Endocrinology, 58, 696-703.
http://dx.doi.org/10.1046/j.1365-2265.2003.01766.x
[23]  Decruze, S.B. and Green, J.A. (2007) Hormone Therapy in Advanced and Recurrent Endometrial Cancer: A Systematic Review. International Journal of Gynecological Cancer, 17, 964-978.
http://dx.doi.org/10.1111/j.1525-1438.2007.00897.x
[24]  Zakikhani, M., Dowling, R., Fantus, I.G., Sonenberg, N. and Pollak, M. (2006) Metformin Is an AMP Kinase-Dependent Growth Inhibitor for Breast Cancer Cells. Cancer Research, 66, 10269-10273.
http://dx.doi.org/10.1158/0008-5472.CAN-06-1500
[25]  Dowling, R.J., Zakikhani, M., Fantus, I.G., Pollak, M. and Sonenberg, N. (2007) Metformin Inhibits Mammalian Target of Rapamycin-Dependent Translation Initiation in Breast Cancer Cells. Cancer Research, 67, 10804-10812.
http://dx.doi.org/10.1158/0008-5472.CAN-07-2310
[26]  Gotlieb, W.H., Saumet, J., Beauchamp, M.C., Gu, J., Lau, S., Pollak, M.N. and Bruchim, I. (2008) In Vitro Metformin Anti-Neoplastic Activity in Epithelial Ovarian Cancer. Gynecologic Oncology, 110, 246-250.
http://dx.doi.org/10.1016/j.ygyno.2008.04.008
[27]  Wang, L.W., Li, Z.S., Zou, D.W., Jin, Z.D., Gao, J. and Xu, G.M. (2008) Metformin Induces Apoptosis of Pancreatic Cancer Cells. World Journal of Gastroenterology, 14, 7192-7198.
http://dx.doi.org/10.3748/wjg.14.7192
[28]  Ben Sahra, I., Laurent, K., Loubat, A., Giorgetti-Peraldi, S., Colosetti, P., Auberger, P., Tanti, J.F., Le Marchand-Brustel, Y. and Bost, F. (2008) The Antidiabetic Drug Metformin Exerts an Antitumoral Effect in Vitro and in Vivo through a Decrease of Cyclin D1 Level. Oncogene, 27, 3576-3586.
http://dx.doi.org/10.1038/sj.onc.1211024
[29]  Cantrell, L.A., Zhou, C., Mendivil, A., Malloy, K.M., Gehrig, P.A. and Bae-Jump, V.L. (2010) Metformin Is a Potent Inhibitor of Endometrial Cancer Cell Proliferation: Implications for a Novel Treatment Strategy. Gynecologic Oncology, 116, 92-98.
http://dx.doi.org/10.1016/j.ygyno.2009.09.024
[30]  Ko, E.M., Walter, P., Jackson, A., Clark, L., Franasiak, J., Bolac, C., Havrilesky, L.J., Secord, A.A., Moore, D.T., Gehrig, P.A. and Bae-Jump, V. (2014) Metformin Is Associated with Improved Survival in Endometrial Cancer. Gynecologic Oncology, 132, 438-442.
http://dx.doi.org/10.1016/j.ygyno.2013.11.021
[31]  Nevadunsky, N.S., Van Arsdale, A., Strickler, H.D., Moadel, A., Kaur, G., Frimer, M., Conroy, E., Goldberg, G.L. and Einstein, M.H. (2014) Metformin Use and Endometrial Cancer Survival. Gynecologic Oncology, 132, 236-240.
http://dx.doi.org/10.1016/j.ygyno.2013.10.026
[32]  Jobo, T., Yonaha, H., Iwaya, H., Kanai, T. and Kuramoto, H. (2000) Conservative Surgery for Malignant Ovarian Tumor in Women of Childbearing Age. International Journal of Clinical Oncology, 5, 41-47.
http://dx.doi.org/10.1007/s101470050008
[33]  Zanetta, G., Rota, S., Chiari, S., Bonazzi, C., Bratina, G. and Mangioni, C. (2001) Behavior of Borderline Tumors with Particular Interest to Persistence, Recurrence, and Progression to Invasive Carcinoma: A Prospective Study. Journal of Clinical Oncology, 19, 2658-2664.
[34]  Li, J., Yang, W. and Wu, X. (2007) Prognostic Factors and Role of Salvage Surgery in Chemorefractory Ovarian Germ Cell Malignancies: A Study in Chinese Patients. Gynecologic Oncology, 105, 769-775.
http://dx.doi.org/10.1016/j.ygyno.2007.02.032
[35]  Bajorin, D.F., Sarosdy, M.F., Pfister, D.G., Mazumdar, M., Motzer, R.J., Scher, H.I., Geller, N.L., Fair, W.R., Herr, H. and Sogani, P. (1993) Randomized Trial of Etoposide and Cisplatin versus Etoposide and Carboplatin in Patients with Good-Risk Germ Cell Tumors: A Multiinstitutional Study. Journal of Clinical Oncology, 11, 598-606.
[36]  Satoh, T., Hatae, M., Watanabe, Y., Yaegashi, N., Ishiko, O., Kodama, S., Yamaguchi, S., Ochiai, K., Takano, M., Yokota, H., Kawakami, Y., Nishimura, S., Ogishima, D., Nakagawa, S., Kobayashi, H., Shiozawa, T., Nakanishi, T., Kamura, T., Konishi, I. and Yoshikawa, H. (2010) Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patient Selection. Journal of Clinical Oncology, 28, 1727-1732.
http://dx.doi.org/10.1200/JCO.2009.24.8617
[37]  Trillsch, F., Mahner, S., Woelber, L., Vettorazzi, E., Reuss, A., Ewald-Riegler, N., de Gregorio, N., Fotopoulou, C., Schmalfeldt, B., Burges, A., Hilpert, F., Fehm, T., Meier, W., Hillemanns, P., Hanker, L., Hasenburg, A., Strauss, H.G., Hellriegel, M., Wimberger, P., Baumann, K., Keyver-Paik, M.D., Canzler, U., Wollschlaeger, K., Forner, D., Pfisterer, J., Schroeder, W., Muenstedt, K., Richter, B., Kommoss, F., Hauptmann, S. and du Bois, A. (2014) Age-Dependent Differences in Borderline Ovarian Tumours (BOT) Regarding Clinical Characteristics and Outcome: Results from a Sub-Analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT Study. Annals of Oncology, 25, 1320-1327.
http://dx.doi.org/10.1093/annonc/mdu119
[38]  Uzan, C., Kane, A., Rey, A., Gouy, S., Duvillard, P. and Morice, P. (2010) Outcomes after Conservative Treatment of Advanced-Stage Serous Borderline Tumors of the Ovary. Annals of Oncology, 21, 55-60.
http://dx.doi.org/10.1093/annonc/mdp267
[39]  Mangili, G., Sigismondi, C., Gadducci, A., Cormio, G., Scollo, P., Tateo, S., Ferrandina, G., Greggi, S., Candiani, M. and Lorusso, D. (2011) Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors: A MITO-9 Retrospective Study. International Journal of Gynecological Cancer, 21, 1414-1421.
http://dx.doi.org/10.1097/IGC.0b013e3182236582
[40]  Pavlidis, N.A. (2002) Coexistence of Pregnancy and Malignancy. Oncologist, 7, 279-287.
http://dx.doi.org/10.1634/theoncologist.7-6-573
[41]  Kal, H.B. and Struikmans, H. (2005) Radiotherapy during Pregnancy: Fact and Fiction. The Lancet Oncology, 6, 328-333.
http://dx.doi.org/10.1016/S1470-2045(05)70169-8
[42]  Hertel, H., Possover, M., Kühne-Heid, R. and Schneider, A. (2001) Laparoscopic Lymph Node Staging of Cervical Cancer in the 19th Week of Pregnancy. A Case Report. Surgical Endoscopy, 15, 324.
http://dx.doi.org/10.1007/s004640042005
[43]  Alouini, S., Rida, K. and Mathevet, P. (2008) Cervical Cancer Complicating Pregnancy: Implications of Laparoscopic Lymphadenectomy. Gynecologic Oncology, 108, 472-477.
http://dx.doi.org/10.1016/j.ygyno.2007.12.006
[44]  Covell, L.M., Disciullo, A.J. and Knapp, R.C. (1977) Decidual Change in Pelvic Lymph Nodes in the Presence of Cervical Squamous Cell Carcinoma during Pregnancy. American Journal of Obstetrics & Gynecology, 127, 674-676.
[45]  Schmeler, K.M., Frumovitz, M. and Ramirez, P.T. (2011) Conservative Management of Early Stage Cervical Cancer: Is There a Role for Less Radical Surgery? Gynecologic Oncology, 120, 321-325.
http://dx.doi.org/10.1016/j.ygyno.2010.12.352
[46]  Morice, P., Uzan, C., Gouy, S., Verschraegen, C. and Haie-Meder, C. (2012) Gynaecological Cancers in Pregnancy. Lancet, 379, 558-569.
http://dx.doi.org/10.1016/S0140-6736(11)60829-5
[47]  Ungár, L., Smith, J.R., Pálfalvi, L. and Del Priore, G. (2006) Abdominal Radical Trachelectomy during Pregnancy to Preserve Pregnancy and Fertility. Obstetrics & Gynecology, 108, 811-814.
http://dx.doi.org/10.1097/01.AOG.0000216015.15415.5f
[48]  Iwami, N., Ishioka, S., Endo, T., Baba, T., Nagasawa, K., Takahashi, M., Sugio, A., Takada, S., Mariya, T., Mizunuma, M. and Saito, T. (2011) First Case of Vaginal Radical Trachelectomy in a Pregnant Japanese Woman. International Journal of Clinical Oncology, 16, 737-740.
http://dx.doi.org/10.1007/s10147-011-0209-3
[49]  Aoki, Y., Inamine, M., Ohishi, S., Nagai, Y. and Masamoto, H. (2014) Radical Abdominal Trachelectomy for IB1 Cervical Cancer at 17 Weeks of Gestation: A Case Report and Literature Review. Case Reports in Obstetrics and Gynecology, 2014, Article ID: 926502.
http://dx.doi.org/10.1155/2014/926502
[50]  Rydzewska, L., Tierney, J., Vale, C.L. and Symonds, P.R. (2012) Neoadjuvant Chemotherapy plus Surgery versus Surgery for Cervical Cancer. Cochrane Database of Systematic Reviews, No. 12, Article No.: CD007406.
http://dx.doi.org/10.1002/14651858.cd007406.pub3
[51]  Amant, F., Halaska, M.J., Fumagalli, M., Dahl Steffensen, K., Lok, C., Van Calsteren, K., Han, S.N., Mir, O., Fruscio, R., Uzan, C., Maxwell, C., Dekrem, J., Strauven, G., Mhallem Gziri, M., Kesic, V., Berveiller, P., van den Heuvel, F., Ottevanger, P.B., Vergote, I., Lishner, M., Morice, P. and Nulman, I. (2014) Gynecologic Cancers in Pregnancy: Guidelines of a Second International Consensus Meeting. International Journal of Gynecological Cancer, 24, 394-403.
http://dx.doi.org/10.1097/IGC.0000000000000062
[52]  Zagouri, F., Sergentanis, T.N., Chrysikos, D. and Bartsch, R. (2013) Platinum Derivatives during Pregnancy in Cervical Cancer: A Systematic Review and Meta-Analysis. Obstetrics & Gynecology, 121, 337-343.
[53]  Van Calsteren, K., Verbesselt, R., Ottevanger, N., Halaska, M., Heyns, L., Van Bree, R., de Bruijn, E., Chai, D., Delforge, M., Noens, L., Renard, V., Witteveen, E., Rob, L., de Hoon, J. and Amant, F. (2010) Pharmacokinetics of Chemotherapeutic Agents in Pregnancy: A Preclinical and Clinical Study. Acta Obstetricia et Gynecologica Scandinavica, 89, 1338-1345.
http://dx.doi.org/10.3109/00016349.2010.512070
[54]  Amant, F., von Minckwitz, G., Han, S.N., Bontenbal, M., Ring, A.E., Giermek, J., Wildiers, H., Fehm, T., Linn, S.C., Schlehe, B., Neven, P., Westenend, P.J., Muller, V., Van Calsteren, K., Rack, B., Nekljudova, V., Harbeck, N., Untch, M., Witteeen, P.O., Schwedler, K., Thomssen, C., Van Calster, B. and Loibi, S. (2013) Prognosis of Women with Primary Breast Cancer Diagnosed during Pregnancy: Results from an International Collaborative Study. Journal of Clinical Oncology, 31, 2532-2539.
http://dx.doi.org/10.1200/JCO.2012.45.6335
[55]  Hoover, K. and Jenkins, T.R. (2011) Evaluation and Management of Adnexal Mass in Pregnancy. American Journal of Obstetrics & Gynecology, 205, 97-102.
http://dx.doi.org/10.1016/j.ajog.2011.01.050
[56]  Leiserowitz, G.S. (2006) Managing Ovarian Masses during Pregnancy. Obstetrical & Gynecological Survey, 61, 463-470.
http://dx.doi.org/10.1097/01.ogx.0000224614.51356.b7
[57]  Aggarwal, P. and Kehoe, S. (2011) Ovarian Tumours in Pregnancy: A Literature Review. European Journal of Obstetrics & Gynecology and Reproductive Biology, 155, 119-124.
http://dx.doi.org/10.1016/j.ejogrb.2010.11.023
[58]  Mathevet, P., Nessah, K., Darget, D. and Mellier, G. (2003) Laparoscopic Management of Adnexal Masses in Pregnancy: A Case Series. European Journal of Obstetrics & Gynecology and Reproductive Biology, 108, 217-222.
http://dx.doi.org/10.1016/s0301-2115(02)00374-3
[59]  Mir, O., Berveiller, P., Ropert, S., Goffinet, F., Pons, G., Treluyer, J.M. and Goldwasser, F. (2008) Emerging Therapeutic Options for Breast Cancer Chemotherapy during Pregnancy. Annals of Oncology, 19, 607-613.
http://dx.doi.org/10.1093/annonc/mdm460
[60]  Van Calsteren, K., Heyns, L., De Smet, F., Van Eycken, L., Gziri, M.M., Van Gemert, W., Halaska, M., Vergote, I., Ottevanger, N. and Amant, F. (2010) Cancer during Pregnancy: An Analysis of 215 Patients Emphasizing the Obstetrical and the Neonatal Outcomes. Journal of Clinical Oncology, 28, 683-689.
http://dx.doi.org/10.1200/JCO.2009.23.2801
[61]  Cardonick, E. and Iacobucci, A. (2004) Use of Chemotherapy during Human Pregnancy. The Lancet Oncology, 5, 283-291.
http://dx.doi.org/10.1016/S1470-2045(04)01466-4
[62]  Amant, F., Van Calsteren, K., Halaska, M.J., Gziri, M.M., Hui, W., Lagae, L., Willemsen, M.A., Kapusta, L., Van Calster, B., Wouters, H., Heyns, L., Han, S.N., Tomek, V., Mertens, L. and Ottevanger, P.B. (2012) Long-Term Cognitive and Cardiac Outcomes after Prenatal Exposure to Chemotherapy in Children Aged 18 Months or Older: An Observational Study. The Lancet Oncology, 13, 256-264.
http://dx.doi.org/10.1016/S1470-2045(11)70363-1
[63]  Gziri, M.M., Debiève, F., DECatte, L., Mertens, L., Barrea, C., van Calsteren, K., Han, S.N., Heyns, L. and Amant, F. (2012) Chemotherapy during Pregnancy: Effect of Anthracyclines on Fetal and Maternal Cardiac Function. Acta Obstetricia et Gynecologica Scandinavica, 91, 1465-1468.
http://dx.doi.org/10.1111/j.1600-0412.2012.01524.x
[64]  Gurumurthy, M., Koh, P., Singh, R., Bhide, A., Satodia, P., Hocking, M., Anbarasu, A. and Wood, L.E. (2009) Metastatic Non-Small-Cell Lung Cancer and the Use of Gemcitabine during Pregnancy. Journal of Perinatology, 29, 63-65.
http://dx.doi.org/10.1038/jp.2008.128
[65]  Prat, J. (2015) FIGO’s Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum: Abridged Republication. Journal of Gynecologic Oncology, 26, 87-89.
http://dx.doi.org/10.3802/jgo.2015.26.2.87
[66]  Chen, C.H., Chiu, L.H., Chan, C. and Liu, W.M. (2015) Management of Ovarian Cancer in 14th Gestational Week of Pregnancy by Robotic Approach with Preservation of the Fetus. Gynecologic and Obstetric Investigation, 80, 139-144.
http://dx.doi.org/10.1159/000368231
[67]  Machado, F., Vegas, C., Leon, J., Perez, A., Sanchez, R., Parrilla, J.J. and Abad, L. (2007) Ovarian Cancer during Pregnancy: Analysis of 15 Cases. Gynecologic Oncology, 105, 446-450.
http://dx.doi.org/10.1016/j.ygyno.2007.01.002
[68]  Tewari, K., Brewer, C., Cappuccini, F., Macri, C., Rogers, L.W. and Berman, M.L. (1997) Advanced-Stage Small Cell Carcinoma of the Ovary in Pregnancy: Long-Term Survival after Surgical Debulking and Multiagent Chemotherapy. Gynecologic Oncology, 66, 531-534.
http://dx.doi.org/10.1006/gyno.1997.4801
[69]  Mancari, R., Tomasi-Cont, N., Sarno, M.A., Azim Jr., H.A., Franchi, D., Carinelli, S., Biglia, N., Colombo, N. and Peccatori, F.A. (2014) Treatment Options for Pregnant Women with Ovarian Tumors. International Journal of Gynecological Cancer, 24, 967-972.
http://dx.doi.org/10.1097/IGC.0000000000000161
[70]  Zagouri, F., Sergentanis, T.N., Chrysikos, D., Filipits, M. and Bartsch, R. (2012) Taxanes for Ovarian Cancer during Pregnancy: A Systematic Review. Oncology, 83, 234-238.
http://dx.doi.org/10.1159/000341351
[71]  Lambertini, M., Peccatori, F.A. and Azim Jr., H.A. (2014) Targeted Agents for Cancer Treatment during Pregnancy. Cancer Treatment Reviews, 41, 301-309.
http://dx.doi.org/10.1016/j.ctrv.2015.03.001
[72]  Sood, A.K., Shahin, M.S. and Sorosky, J.I. (2001) Paclitaxel and Platinum Chemotherapy for Ovarian Carcinoma during Pregnancy. Gynecologic Oncology, 83, 599-600.
http://dx.doi.org/10.1006/gyno.2001.6439
[73]  Motegi, M., Takakura, S., Takano, H., Tanaka, T. and Ochiai, K. (2007) Adjuvant Chemotherapy in a Pregnant Woman with Endodermal Sinus Tumor of the Ovary. Obstetrics & Gynecology, 109, 537-540.
http://dx.doi.org/10.1097/01.AOG.0000245450.62758.47
[74]  Ataya, K., Rao, L.V., Lawrence, E. and Kimmel, R. (1995) Luteinizing Hormone-Releasing Hormone Agonist Inhibits Cyclophosphamide-Induced Ovarian Follicular Depletion in Rhesus Monkeys. Biology of Reproduction, 52, 365-372.
http://dx.doi.org/10.1095/biolreprod52.2.365
[75]  Blumenfeld, Z. (2001) Ovarian Rescue/Protection from Chemotherapeutic Agents. Journal of the Society for Gynecologic Investigation, 8, S60-S64.
http://dx.doi.org/10.1016/S1071-5576(00)00112-X
[76]  Beck-Fruchter, R., Weiss, A. and Shalev, E. (2008) GnRH Agonist Therapy as Ovarian Protectants in Female Patients Undergoing Chemotherapy: A Review of the Clinical Data. Human Reproduction Update, 14, 553-561.
http://dx.doi.org/10.1093/humupd/dmn041
[77]  Munster, P.N., Moore, A.P., Ismail-Khan, R., Cox, C.E., Lacevic, M., Gross-King, M., Xu, P., Carter, W.B. and Minton, S.E. (2012) Randomized Trial Using Gonadotropin-Releasing Hormone Agonist Triptorelin for the Preservation of Ovarian Function during (Neo) Adjuvant Chemotherapy for Breast Cancer. Journal of Clinical Oncology, 10, 533-538.
http://dx.doi.org/10.1200/JCO.2011.34.6890
[78]  Chen, H., Wang, Y., Lyu, Q., Ai, A., Fu, Y., Tian, H., Cai, R., Hong, Q., Chen, Q., Shoham, Z. and Kuang, Y. (2015) Comparison of Live-Birth Defects after Luteal-Phase Ovarian Stimulation vs. Conventional Ovarian Stimulation for in Vitro Fertilization and Vitrified Embryo Transfer Cycles. Fertility and Sterility, 103, 1194-1201.
http://dx.doi.org/10.1016/j.fertnstert.2015.02.020
[79]  Dolmans, M.M., Demylle, D., Martinez-Madrid, B. and Donnez, J. (2005) Efficacy of in Vitro Fertilization after Chemotherapy. Fertility and Sterility, 83, 897-901.
http://dx.doi.org/10.1016/j.fertnstert.2004.08.035
[80]  Goldman, K.N., Noyes, N.L., Knopman, J.M., McCaffrey, C. and Grifo, J.A. (2013) Oocyte Efficiency: Does Live Birth Rate Differ When Analyzing Cryopreserved and Fresh Oocytes on a Per-Oocyte Basis? Fertility and Sterility, 100, 712-717.
http://dx.doi.org/10.1016/j.fertnstert.2013.04.040
[81]  Oktay, K. and Karlikaya, G. (2000) Ovarian Function after Transplantation of Frozen, Banked Autologous Ovarian Tissue. The New England Journal of Medicine, 342, 1919.
http://dx.doi.org/10.1056/NEJM200006223422516
[82]  Donnez, J., Dolmans, M.M., Demylle, D., Jadoul, P., Pirard, C., Squifflet, J., Martinez-Madrid, B. and van Langendonckt, A. (2004) Livebirth after Orthotopic Transplantation of Cryopreserved Ovarian Tissue. Lancet, 364, 1405-1410.
http://dx.doi.org/10.1016/S0140-6736(04)17222-X
[83]  Demeestere, I., Simon, P., Dedeken, L., Moffa, F., Tsépélidis, S., Brachet, C., Delbaere, A., Devreker, F. and Ferster, A. (2015) Live Birth after Autograft of Ovarian Tissue Cryopreserved during Childhood. Human Reproduction, 30, 2107-2109.
http://dx.doi.org/10.1093/humrep/dev128
[84]  Dolmans, M.M., Luyckx, V., Donnez, J., Anderson, C.Y. and Greve, T. (2013) Risk of Transferring Malignant Cells with Transplanted Frozen-Thawed Ovarian Tissue. Fertility and Sterility, 99, 1514-1522.
http://dx.doi.org/10.1016/j.fertnstert.2013.03.027
[85]  Chan, P.G., Sung, H.Y. and Sawaya, G.F. (2003) Changes in Cervical Cancer Incidence after Three Decades of Screening US Women Less than 30 Years Old. Obstetrics & Gynecology, 102, 765-773.
http://dx.doi.org/10.1016/S0029-7844(03)00696-3
[86]  Touhami, O. and Plante, M. (2015) Should Ovaries Be Removed or Not in (Early-Stage) Adenocarcinoma of the Uterine Cervix: A Review. Gynecologic Oncology, 136, 384-388.
http://dx.doi.org/10.1016/j.ygyno.2014.12.011
[87]  Bastings, L., Beerendonk, C.C., Westphal, J.R., Massuger, L.F., Kaal, S.E., van Leeuwen, F.E., Braat, D.D. and Peek, R. (2013) Autotransplantation of Cryopreserved Ovarian Tissue in Cancer Survivors and the Risk of Reintroducing Malignancy: A Systematic Review. Human Reproduction Update, 19, 483-506.
http://dx.doi.org/10.1093/humupd/dmt020
[88]  Tomao, F., Peccatori, F., Pup, L.D., Franchi, D., Zanagnolo, V., Panici, P.B. and Colombo, N. (2015) Special Issues in Fertility Preservation for Gynecologic Malignancies. Critical Reviews in Oncology/Hematology, Epub ahead of print.
[89]  Fageeh, W., Raffa, H., Jabbad, H. and Marzouki, A. (2002) Transplantation of the Human Uterus. International Journal of Gynecology & Obstetrics, 76, 245-251.
http://dx.doi.org/10.1016/s0020-7292(01)00597-5
[90]  Erman Akar, M., Ozkan, O., Aydinuraz, B., Dirican, K., Cincik, M., Mendilcioglu, I., Simsek, M., Gunseren, F., Kocak, H., Ciftcioglu, A., Gecici, O. and Ozkan, O. (2013) Clinical Pregnancy after Uterus Transplantation. Fertility and Sterility, 100, 1358-1363.
http://dx.doi.org/10.1016/j.fertnstert.2013.06.027
[91]  Brannstrom, M., Johannesson, L., Bokstrom, H., Kvarnstrom, N., Molne, J., Dahm-Kahler, P., Enskog, A., Milenkovic, M., Ekberg, J., Diaz-Garcia, C., Gabel, M., Hanafy, A., Hagberg, H., Olausson, M. and Nilsson, L. (2015) Live Birth after Uterus Transplantation. Lancet, 385, 607-616.
http://dx.doi.org/10.1016/S0140-6736(14)61728-1
[92]  Brannstrom, M., Johannesson, L., Dahm-Kahler, P., Enskog, A., Molne, J., Kvarnstrom, N., Diaz-Garcia, C., Hanafy, A., Lundmark, C., Marcickiewicz, J., Gabel, M., Groth, K., Akouri, R., Eklind, S., Holgersson, J., Tzakis, A. and Olausson, M. (2014) First Clinical Uterus Transplantation Trial: A Six-Month Report. Fertility and Sterility, 101, 1228-1236.
http://dx.doi.org/10.1016/j.fertnstert.2014.02.024
[93]  Vajdic, C.M., McDonald, S.P., McCredie, M.R., van Leeuwen, M.T., Stewart, J.H., Law, M., Chapman, J.R., Webster, A.C., Kaldor, J.M. and Grulich, A.E. (2006) Cancer Incidence before and after Kidney Transplantation. JAMA, 296, 2823-2831.
http://dx.doi.org/10.1001/jama.296.23.2823
[94]  Ozsaran, A.A., Ates, T., Dikmen, Y., Zeytinoglu, A., Terek, C., Erhan, Y., Ozacar, T. and Bilgic, A. (1999) Evaluation of the Risk of Cervical Intraepithelial Neoplasia and Human Papilloma Virus Infection in Renal Transplant Patients Receiving Immunosuppressive Therapy. European Journal of Gynaecological Oncology, 20, 127-130.
[95]  Kisu, I., Banno, K., Mihara, M., Suganuma, N. and Aoki, D. (2013) Current Status of Uterus Transplantation in Primates and Issues for Clinical Application. Fertility and Sterility, 100, 280-294.
http://dx.doi.org/10.1016/j.fertnstert.2013.03.004
[96]  Kisu, I., Banno, K., Mihara, M., Hara, H., Umene, K., Adachi, M., Nogami, Y. and Aoki, D. (2015) A Surgical Technique Using the Ovarian Vein in Non-Human Primate Models of Potential Living-Donor Surgery of Uterus Transplantation. Acta Obstetricia et Gynecologica Scandinavica, 94, 942-948.
http://dx.doi.org/10.1111/aogs.12701
[97]  Kisu, I., Mihara, M., Banno, K., Hara, H., Masugi, Y., Araki, J., Iida, T., Yamada, Y., Kato, Y., Shiina, T., Suganuma, N. and Aoki, D. (2014) Uterus Allotransplantation in Cynomolgus Macaque: A Preliminary Experience with Non-Human Primate Models. Journal of Obstetrics and Gynaecology Research, 40, 907-918.
http://dx.doi.org/10.1111/jog.12302

Full-Text

comments powered by Disqus